Cerenome
Houston, Texas, United States · Biotechnology, Health Care, Health Diagnostics
Cerenome is a CNS oncology company advancing an integrated platform that combines precision diagnostics, targeted therapeutics, and artificial intelligence to improve outcomes for patients with central nervous system cancers. The Company’s CNSide Diagnostics platform supports the detection, molecular characterization, and monitoring of CNS cancers through cerebrospinal fluid-based testing. Its lea
Key facts
- Headquarters
- Houston, Texas, United States
- Employees
- 28
- Industries
- Biotechnology, Health Care, Health Diagnostics
- Status
- Public (CNSY)
- Website
- cerenome.com
Recent activity at Cerenome
Cerenome funding history
| Date | Round | Amount |
|---|---|---|
| Sep 2026 | Debt Financing | $20.0M |
Leadership
- Marc, President & CEO
- Mia, Associate Director, Human Resources
- Michelle, Vice President Clinical Operations
Verified email and direct lines for Cerenome’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Cerenome in the news
- Plus Tx rebrands as Cerenome as it deepens AI strategy - Fierce Pharma (Jul 01, 2026)
- Cerenome (CNSY) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance (Aug 14, 2026)
- Radiation therapy co. Cerenome plans major expansion at Hines' Levit Green campus - The Business Journals (Aug 20, 2026)
- Cerenome to Host September 30 Conference Call on CNSide Diagnostics Business Update - Quiver Quantitative (Sep 25, 2026)
- Cerenome Launches as an Integrated CNS Oncology Company - GlobeNewswire (Jul 31, 2026)
- Cerenome Secures Up to $20 Million Senior Secured Financing to Support CNSide Commercial Scale-Up - Quiver Quantitative (Sep 10, 2026)
- Cerenome (NasdaqCM:CNSY) Stock Price - Simply Wall Street (Aug 03, 2026)
- Cerenome Reports CNSide Q3 2026 Progress on Coverage Expansion, Medicare Pricing and Testing Menu Growth - Quiver Quantitative (Sep 30, 2026)
Companies similar to Cerenome
- bioAffinity Technologies · Biotechnology, Health Care, Health Diagnostics, Therapeutics
- Inoviq Ltd · Biotechnology, Health Care, Health Diagnostics, Therapeutics
- Lifesenz Cancer Research Labs Private Limited · Biotechnology, Health Care, Health Diagnostics, Therapeutics
- Oxford Brain Diagnostics · Biotechnology, Health Care, Health Diagnostics, Therapeutics
- Creatv MicroTech · Biotechnology, Health Care, Health Diagnostics, Therapeutics
About Cerenome: questions and answers
What does Cerenome do?
Cerenome is a CNS oncology company advancing an integrated platform that combines precision diagnostics, targeted therapeutics, and artificial intelligence to improve outcomes for patients with central nervous system cancers. The Company’s CNSide Diagnostics platform supports the detection, molecular characterization, and monitoring of CNS cancers through cerebrospinal fluid-based testing. Its lea
Where is Cerenome headquartered?
Cerenome is headquartered in Houston, Texas, United States.
How many employees does Cerenome have?
Cerenome has about 28 employees.
Has Cerenome raised funding?
Yes. Fundz has recorded 1 funding event for Cerenome. The most recent, Debt Financing of $20.0M, was in Sep 2026.
Who leads Cerenome?
Marc is a President & CEO at Cerenome.
What is the latest news on Cerenome?
On Sep 10, 2026, Cerenome, Inc. has secured up to $20 million in a financing facility with 3i Fund to support the commercial scale-up of its CNSide platform. The initial tranche of funding was received at closing with future tranches tied to milestones.
Is Cerenome a public company?
Yes. Cerenome is publicly traded under the ticker CNSY.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy